(Q33377239)
Statements
A randomized, phase II trial of two dose levels of temsirolimus (CCI-779) in patients with extensive-stage small-cell lung cancer who have responding or stable disease after induction chemotherapy: a trial of the Eastern Cooperative Oncology Group (E1500) (English)
Kishan J Pandya
Roger B Cohen
Martin W Lee
Joan H Schiller
David H Johnson
Eastern Cooperative Oncology Group (E1500)